Close
Find your Coloplast country website

News and press releases

  • Press release
4 Feb 2025
Coloplast expands Peristeen Light® portfolio with new product launch

Coloplast expands Peristeen Light® portfolio with new product launch

The new product, Peristeen Light 250mL, features a larger water container and an optional extension tube, offering people living with constipation and faecal incontinence more flexibility in their daily bowel care routines.

Read news story

This marks Coloplast’s second launch within Bowel Care in 12 months, reflecting the company’s commitment to bringing new innovation to people living with bowel dysfunction.

“We want to break down the barriers around transanal irrigation – a proven and effective treatment1 that can help many more people than it does today. Peristeen Light is designed to be intuitive and easy to use. With this launch, we’re expanding our offering to meet the individual needs of people living with constipation and faecal incontinence,” says Marie Smidt, Vice President of Bowel Care at Coloplast.

The Peristeen Light 250mL, available with or without an extension tube, builds on the launch of Peristeen Light 175mL in February 2024. The 250mL product will launch in Denmark, Sweden, Norway, Finland, Switzerland, Spain and the Netherlands from February 2025 and is expected to be available in all key European markets within 12 months*.

 

Peristeen Light

Peristeen Light is a hand-held, low-volume transanal irrigation device that instills water into the rectum, thereby evacuating the stool from the lower bowel. Peristeen Light is designed based on 20 years of insights from Coloplast’s high-volume transanal irrigation device, Peristeen Plus. Peristeen Light is designed to be intuitive and easy to use, assembled in just two steps, and enables a smooth insertion into the rectum with a soft and flexible catheter.

 

A growth driver in Bowel Care

The Peristeen Light is a new transanal irrigation device within Coloplast’s Bowel Care segment. The addressable market for bowel care, comprised of transanal irrigation treatment, is estimated at around DKK 1 billion, with growth of around double-digit. Peristeen Light is expected to contribute to Coloplast’s growth trajectory for Bowel Care and help solidify the company’s global market leader position within transanal irrigation.

 

 

Contacts

Peter Mønster

Sr. Media Relations Manager

+45 4911 2623

dkpete@coloplast.com

 

Aleksandra Dimovska

Vice President of Investor Relations

+45 4911 2458

dkadim@coloplast.com

 

 

1 Christensen P, Bazzocchi G, Coggrave M, et al., A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006; 131(3):738-47
*Peristeen Light is a CE-marked medical device. Availability is dependent on the individual country's regulatory process. Not available in the US.
View desktop version